A protein that promotes cancer may be the key to its treatment
- Activating the PPARD protein in immune cells can enhance their effectiveness in fighting cancer
- The study focuses on colorectal cancer, which is growing among young people.
- The possibilities of applying the method to other diseases remain open.
Protein PPARD: a dual role in cancer and immunotherapy.
Recent studies conducted by scientists from Cold Spring Harbor Laboratory revealed an interesting dual role of the protein PPARD, which, on one hand, promotes the growth of cancer cells, and on the other hand, can become a powerful tool in the fight against tumors. Activation of this protein in immune cells can significantly enhance their ability to attack cancer formations, opening new horizons in cancer treatment, especially colorectal cancer, which has become the leading cause of cancer death among people under 50.
The study, published in the journal Nature Immunology, led by Assistant Professor Semir Beyaz, focuses on the metabolic health of cells. The scientists suggested that the factors affecting the fitness of cancer and immune cells may be similar, as both groups of cells are subject to the same chemical and physical laws. This discovery became the basis for further experiments with PPARD, which regulates how cells burn fat for energy.
In experiments on mice with colorectal cancer, scientists found that activating PPARD in immune cells creates an environment conducive to attacking tumors. This discovery highlights the importance of cellular metabolism in the fight against cancer. Beyaz noted, "When immune cells burn more fat, they become better prepared to fight cancer."
The study and its results
The next step was to investigate the possibility of enhancing the ability of immune cells to attack human colorectal cancer using modified CAR T-cells. These cells, already used in the therapy of certain types of cancer, were activated to increase PPARD activity. The results showed that such cells slow down or stop tumor growth in various experimental models, including organoids and cell cultures implanted in mice.
Although the study results are promising, it is important to note that this approach has not yet been tested on patients. Nevertheless, the research opens new possibilities for improving existing immunotherapies, which is particularly relevant for patients with hard-to-treat forms of cancer, such as colorectal cancer.
Research has also shown promising results regarding other types of cancer, including breast cancer, ovarian cancer, and melanoma. This raises the question of whether improving the fitness of immune cells could become a broader strategy for treating tumors that are difficult to control with current methods.
The potential for cancer treatment
Beyaz believes that these discoveries represent only the "tip of the iceberg" in the search for new ways to strengthen cancer immunotherapy. He also raises the question of the possibility of applying a similar approach to treat other diseases, such as endometriosis, a chronic inflammatory condition affecting about one in ten women.
Comparing the roles of PPARD in cancer and immune cells, Beyaz uses an analogy with the "Force" from Star Wars. Depending on how this protein is used, it can lead to completely different outcomes. In cancer cells, PPARD supports disease progression, while in immune cells it can help in destroying tumors.
This is a classic struggle between good and evil, as Beyaz says: "How can good ultimately prevail? The activation of PPARD in immune cells may be that very path." This underscores the importance of further research in this area to understand how this protein can be used to improve cancer treatment.
The future of research and application
In conclusion, the discovery of the dual role of PPARD in cancerous and immune cells may change the approach to cancer treatment. Scientists hope that further research will help develop new methods that can effectively utilize this protein to combat various forms of cancer and other diseases related to immune system dysfunction.
As colorectal cancer continues to be a serious health issue, especially among young people, the results of this study may represent an important step towards creating more effective treatment methods. Scientists emphasize the need for further clinical trials to confirm the effectiveness of activating PPARD in cancer therapy.
Thus, the work of the Beyaz group opens new horizons in the fields of oncology and immunology, offering hope for more effective treatment methods that could change the lives of many patients. It is important to continue exploring the potential of PPARD and its impact on immune cells to find new pathways in the fight against cancer.
Source: ScienceDaily
